Prognosis: Doubt
Prognosis: Doubt
Mar 1, 2021
Johnson & Johnson's CEO on the Newest Vaccine
Play • 15 min

Now that Johnson & Johnson’s Covid-19 vaccine has been cleared by regulators, the company needs to ramp up doses fast. J and J is looking for manufacturing partnerships to increase supply. Riley Griffin spoke to the company’s chief executive officer, Alex Gorsky about his plan to immunize 20 million Americans by the end of the month, and 100 million by the end of June.

Search
Clear search
Close search
Google apps
Main menu